Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Prescription Drugs & Other Medical Products

Reports

Displaying 21 - 30 of 209. 10 per page. Page 3.

Advanced Search
ASPE Issue Brief

An Examination of March-in Rights and Drug Products with Government-Interest Patents

March-in authority allows the federal government to grant licenses on privately owned patents for inventions developed with federal funding provided certain statutory requirements are met. It was designed to ensure that the benefits of the American taxpayers’ investment in research and development are reasonably accessible to the public.
Report

Estimating the Effects of the Medicare $2 Drug List on Part D Enrollees

The Centers for Medicare & Medicaid Services (CMS) Innovation Center is in the process of developing the Medicare $2 Drug List (M2DL) Model. This would allow Part D plan sponsors to offer a standardized list of generic drugs for a copayment of $2 or less for a month’s supply that would not be subject to prior authorization, quantity limits, or other utilization management restrictions.
ASPE Issue Brief

Characteristics of Part D Drugs in Shortage

In this Report, we matched a sample of Part D drugs and biological products that had price changes between January 2011 and October 2023 to FDA’s January 2023 list of drug shortages database. Then we analyzed price changes that occurred before and after the shortage, overall and by select drug characteristics of interest.
ASPE Issue Brief

Characteristics of Part B Drugs in Shortage

In this Report, we matched a sample of Part B drugs and biological products that had price changes between January 2011 and October 2023 with the FDA’s January 2023 list of drug shortages database. Then we analyzed price changes that occurred before and after the shortage, overall and by select drug characteristics of interest.
Report

Federal Funding Compendium of Crisis Services: Final Report

The Substance Abuse and Mental Health Services Administration (SAMHSA) has recently developed guidelines for establishing a comprehensive crisis response system for behavioral health. Per these guidelines, a comprehensive system should provide individuals in crisis with “someone to call,” “someone to respond,” and “a place to go” to receive crisis response services.
ASPE Issue Brief

Comparing U.S. and International Market Size and Average Pricing for Prescription Drugs, 2017-2022

This issue brief examines trends related to market size measured via sales revenues and volume of prescription drug use between the U.S. and other countries between 2017 and 2023. Specifically, we compare the U.S. to the rest of the world (excluding the U.S.) and the other OECD countries (excluding the U.S.).
Report

Research Applications of Electronic Recovery Records

Recovery support services (RSS) are non-clinical services that assist individuals and families in attaining and sustaining recovery from substance use disorders.
Report

Availability and Correlates of Integrated Treatment for People with Co-Occurring Disorders in Outpatient Behavioral Health Treatment Facilities

People with co-occurring mental health and substance use disorders (SUDs) benefit from integrated treatment to address both disorders concurrently. For several decades, policymakers and behavioral health systems have worked to overcome the historical separation between mental health and SUD treatment to improve care for people with co-occurring disorders.
Report

Health Information Technology Adoption and Utilization in Behavioral Health Settings: Final Report

Health Information Technology (HIT) was identified as a critical component of the HHS Roadmap for Behavioral Health Integration. To support the implementation of the Roadmap, an ASPE study was conducted to provide an overview of HIT adoption and utilization among behavioral health providers.
Report

Wait Time Standards for Behavioral Health Network Adequacy

Insufficient access to behavioral health (BH) care and the inability to get timely care are significant problems in the United States. Concerns about BH network adequacy have been prompted by evidence of narrow networks for BH, variation in network adequacy across plans, and evidence that network adequacy impacts access to certain specialties.